Annual Revenue
$610.78 M
-$7.94 M-1.28%
December 31, 2024
Summary
- As of February 26, 2025, TXG annual revenue is $610.78 million, with the most recent change of -$7.94 million (-1.28%) on December 31, 2024.
- During the last 3 years, TXG annual revenue has risen by +$120.30 million (+24.53%).
- TXG annual revenue is now -1.28% below its all-time high of $618.73 million, reached on December 31, 2023.
Performance
TXG Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$165.02 M
+$13.37 M+8.81%
December 31, 2024
Summary
- As of February 26, 2025, TXG quarterly revenue is $165.02 million, with the most recent change of +$13.37 million (+8.81%) on December 31, 2024.
- Over the past year, TXG quarterly revenue has increased by +$13.37 million (+8.81%).
- TXG quarterly revenue is now -10.30% below its all-time high of $183.98 million, reached on December 31, 2023.
Performance
TXG Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$610.78 M
-$18.96 M-3.01%
December 31, 2024
Summary
- As of February 26, 2025, TXG TTM revenue is $610.78 million, with the most recent change of -$18.96 million (-3.01%) on December 31, 2024.
- Over the past year, TXG TTM revenue has dropped by -$18.96 million (-3.01%).
- TXG TTM revenue is now -3.32% below its all-time high of $631.73 million, reached on June 30, 2024.
Performance
TXG TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TXG Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.3% | +8.8% | -3.0% |
| 3 y3 years | +24.5% | +8.8% | -3.0% |
| 5 y5 years | +148.4% | +8.8% | -3.0% |
TXG Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.3% | +24.5% | -10.3% | +44.1% | -3.3% | +24.5% |
| 5 y | 5-year | -1.3% | +148.4% | -10.3% | +284.6% | -3.3% | +148.4% |
| alltime | all time | -1.3% | +759.2% | -10.3% | +350.8% | -3.3% | +1568.5% |
10x Genomics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $610.78 M(-1.3%) | $165.02 M(+8.8%) | $610.78 M(-3.0%) |
| Sep 2024 | - | $151.65 M(-0.9%) | $629.74 M(-0.3%) |
| Jun 2024 | - | $153.10 M(+8.6%) | $631.73 M(+1.0%) |
| Mar 2024 | - | $141.01 M(-23.4%) | $625.45 M(+1.1%) |
| Dec 2023 | $618.73 M(+19.8%) | $183.98 M(+19.7%) | $618.73 M(+4.7%) |
| Sep 2023 | - | $153.64 M(+4.6%) | $590.98 M(+4.0%) |
| Jun 2023 | - | $146.82 M(+9.3%) | $568.41 M(+6.0%) |
| Mar 2023 | - | $134.28 M(-14.0%) | $536.20 M(+3.8%) |
| Dec 2022 | $516.41 M(+5.3%) | $156.23 M(+19.2%) | $516.41 M(+2.5%) |
| Sep 2022 | - | $131.07 M(+14.4%) | $503.71 M(+1.2%) |
| Jun 2022 | - | $114.61 M(+0.1%) | $497.93 M(-0.2%) |
| Mar 2022 | - | $114.50 M(-20.2%) | $499.17 M(+1.8%) |
| Dec 2021 | $490.49 M | $143.53 M(+14.6%) | $490.49 M(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $125.30 M(+8.2%) | $459.18 M(+13.2%) |
| Jun 2021 | - | $115.84 M(+9.5%) | $405.70 M(+21.9%) |
| Mar 2021 | - | $105.82 M(-5.7%) | $332.76 M(+11.3%) |
| Dec 2020 | $298.85 M(+21.5%) | $112.22 M(+56.3%) | $298.85 M(+14.1%) |
| Sep 2020 | - | $71.82 M(+67.4%) | $261.92 M(+4.2%) |
| Jun 2020 | - | $42.91 M(-40.3%) | $251.31 M(-4.9%) |
| Mar 2020 | - | $71.91 M(-4.5%) | $264.22 M(+7.5%) |
| Dec 2019 | $245.89 M(+68.1%) | $75.29 M(+23.0%) | $245.89 M(+11.2%) |
| Sep 2019 | - | $61.21 M(+9.7%) | $221.16 M(+12.5%) |
| Jun 2019 | - | $55.82 M(+4.2%) | $196.56 M(+39.7%) |
| Mar 2019 | - | $53.58 M(+6.0%) | $140.74 M(+61.5%) |
| Dec 2018 | $146.31 M(+105.8%) | $50.55 M(+38.1%) | $87.16 M(+138.1%) |
| Sep 2018 | - | $36.61 M | $36.61 M |
| Dec 2017 | $71.08 M | - | - |
FAQ
- What is 10x Genomics annual revenue?
- What is the all time high annual revenue for 10x Genomics?
- What is 10x Genomics annual revenue year-on-year change?
- What is 10x Genomics quarterly revenue?
- What is the all time high quarterly revenue for 10x Genomics?
- What is 10x Genomics quarterly revenue year-on-year change?
- What is 10x Genomics TTM revenue?
- What is the all time high TTM revenue for 10x Genomics?
- What is 10x Genomics TTM revenue year-on-year change?
What is 10x Genomics annual revenue?
The current annual revenue of TXG is $610.78 M
What is the all time high annual revenue for 10x Genomics?
10x Genomics all-time high annual revenue is $618.73 M
What is 10x Genomics annual revenue year-on-year change?
Over the past year, TXG annual revenue has changed by -$7.94 M (-1.28%)
What is 10x Genomics quarterly revenue?
The current quarterly revenue of TXG is $165.02 M
What is the all time high quarterly revenue for 10x Genomics?
10x Genomics all-time high quarterly revenue is $183.98 M
What is 10x Genomics quarterly revenue year-on-year change?
Over the past year, TXG quarterly revenue has changed by +$13.37 M (+8.81%)
What is 10x Genomics TTM revenue?
The current TTM revenue of TXG is $610.78 M
What is the all time high TTM revenue for 10x Genomics?
10x Genomics all-time high TTM revenue is $631.73 M
What is 10x Genomics TTM revenue year-on-year change?
Over the past year, TXG TTM revenue has changed by -$18.96 M (-3.01%)